A new trading day began on Friday, with Applied Therapeutics Inc (NASDAQ: APLT) stock price down -3.55% from the previous day of trading, before settling in for the closing price of $9.01. APLT’s price has ranged from $1.79 to $10.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 12.49%. With a float of $84.56 million, this company’s outstanding shares have now reached $84.87 million.
Let’s determine the extent of company efficiency that accounts for 25 employees. In terms of profitability, gross margin is 378.67%, operating margin of 43736.49%, and the pretax margin is 88772.51%.
Applied Therapeutics Inc (APLT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 25.12%, while institutional ownership is 86.88%. The most recent insider transaction that took place on Aug 22 ’24, was worth 78,880. In this transaction Chief Financial Officer of this company sold 13,530 shares at a rate of $5.83, taking the stock ownership to the 277,911 shares. Before that another transaction happened on Aug 22 ’24, when Company’s Chief Medical Officer sold 22,681 for $5.83, making the entire transaction worth $132,230. This insider now owns 986,853 shares in total.
Applied Therapeutics Inc (APLT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 12.49% per share during the next fiscal year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Here are Applied Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 91.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.48 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Looking closely at Applied Therapeutics Inc (NASDAQ: APLT), its last 5-days average volume was 2.18 million, which is a jump from its year-to-date volume of 1.84 million. As of the previous 9 days, the stock’s Stochastic %D was 8.59%. Additionally, its Average True Range was 0.61.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 69.57%, which indicates a significant increase from 14.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.87% in the past 14 days, which was lower than the 105.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.19, while its 200-day Moving Average is $5.94. However, in the short run, Applied Therapeutics Inc’s stock first resistance to watch stands at $8.97. Second resistance stands at $9.25. The third major resistance level sits at $9.40. If the price goes on to break the first support level at $8.54, it is likely to go to the next support level at $8.39. Now, if the price goes above the second support level, the third support stands at $8.11.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
With a market capitalization of 975.23 million, the company has a total of 116,356K Shares Outstanding. Currently, annual sales are 9,990 K while annual income is -119,760 K. The company’s previous quarter sales were 120 K while its latest quarter income was -68,590 K.
